InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51
United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

166
Insider
Date
Role
Action
Shares
Price
Amount
Adrian Rawcliffe
12 Aug 2026
Director
Sold on a plan
12,700
$5.29
$67.18K
Aik Na Tan
11 Aug 2026
Director
Sold on a plan
432
$6.01
$2.60K
Ken Takanashi
11 Aug 2026
Director
Sold on a plan
3,864
$6.01
$23.22K
Heidi L Wagner
11 Aug 2026
Director
Sold after exercise
7,000
$6.01
$42.07K
Ra Capital Management, L.p.
30 Mar 2026
Director
Buy indirect
971,091
$6.50
$6.31M
Ra Capital Management, L.p.
27 Mar 2026
Director
Buy indirect
2,495,623
$6.43
$16.05M
Ra Capital Management, L.p.
26 Mar 2026
Director
Buy indirect
351,224
$6.38
$2.24M
Ra Capital Management, L.p.
26 Mar 2026
Director
Buy indirect
4,954,558
$6.06
$30.02M
Chris Francis
26 Feb 2026
See Remarks
Sold after exercise
15,294
$15.00
$229.41K
Chris Francis
26 Feb 2026
See Remarks
Sold after exercise
17,900
$15.09
$270.18K
Chandra Vargeese
9 Feb 2026
See Remarks
Sell
3,228
$13.45
$43.42K
Chris Francis
9 Feb 2026
See Remarks
Sell
1,883
$13.45
$25.33K
Paul Bolno
9 Feb 2026
President and CEO
Sell
10,480
$13.45
$140.96K
Kyle Moran
9 Feb 2026
Chief Financial Officer
Sell
3,588
$13.45
$48.26K
Chris Francis
2 Jan 2026
See Remarks
Sold after exercise
1,295
$16.70
$21.63K
Chris Francis
2 Jan 2026
See Remarks
Sold after exercise
8,080
$15.92
$128.63K
GSK plc
11 Dec 2025
10% owner
Buy indirect
1,470,000
$19.00
$27.93M
Kyle Moran
9 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$20.03
$1.00M
Kyle Moran
9 Dec 2025
Chief Financial Officer
Sold after exercise
36
$20.25
$729.00
Mark Corrigan
8 Dec 2025
Director
Sold on a plan
6,515
$14.07
$91.63K
Mark Corrigan
8 Dec 2025
Director
Sold on a plan
9,600
$13.09
$125.66K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$18.00
$900.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$13.20
$660.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$15.00
$750.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
60,000
$13.20
$792.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
22,500
$14.08
$316.80K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
50,000
$16.00
$800.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
122,349
$14.20
$1.74M
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
17,900
$15.00
$268.50K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
37,500
$14.08
$528.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
9,375
$15.00
$140.63K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
45,882
$14.50
$665.29K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
107,400
$14.56
$1.56M
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
28,125
$14.50
$407.81K
Gregory L. Verdine
8 Dec 2025
Director
Sold on a plan
7,980
$14.05
$112.12K
Gregory L. Verdine
8 Dec 2025
Director
Sold on a plan
12,020
$13.09
$157.34K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
21,000
$12.75
$267.75K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
21,000
$12.75
$267.75K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
25,000
$15.00
$375.00K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
20,000
$12.75
$255.00K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
17,230
$15.00
$258.45K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
15,000
$12.75
$191.25K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
7,494
$15.00
$112.41K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
7,494
$12.75
$95.55K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
30,000
$18.02
$540.60K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
15,000
$14.07
$211.05K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
42,000
$12.75
$535.50K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
6,445
$12.75
$82.17K
Heidi L Wagner
8 Dec 2025
Director
Sold after exercise
7,000
$14.00
$98.00K
Heidi L Wagner
8 Dec 2025
Director
Sold after exercise
7,000
$13.00
$91.00K
Adrian Rawcliffe
8 Dec 2025
Director
Sold after exercise
42,000
$15.00
$630.00K
Ra Capital Management, L.p.
13 Nov 2025
Director
Buy indirect
1,000
$6.69
$6.69K
Adrian Rawcliffe
13 Nov 2025
Director
Sold on a plan
16,115
$6.79
$109.42K
Paul Bolno
22 Aug 2025
President and CEO
Sold on a plan
217,351
$10.10
$2.19M
Gregory L. Verdine
22 Aug 2025
Director
Sold on a plan
10,000
$10.00
$100.00K
Aik Na Tan
15 Aug 2025
Director
Sold after exercise
21,000
$9.25
$194.25K
Christian O Henry
13 Aug 2025
Director
Sold on a plan
9,670
$8.81
$85.19K
Aik Na Tan
5 Aug 2025
Director
Sold on a plan
1,127
$8.75
$9.86K
Ken Takanashi
5 Aug 2025
Director
Sold on a plan
4,872
$8.75
$42.63K
Gregory L. Verdine
13 Jun 2025
Director
Sold on a plan
30,000
$6.95
$208.50K
Christian O Henry
20 Mar 2025
Director
Sold after exercise
10,500
$9.77
$102.57K
Gregory L. Verdine
7 Mar 2025
Director
Exercised, kept
133,402
$2.48
$330.84K
Paul Bolno
7 Mar 2025
President and CEO
Sold after exercise
169,025
$9.57
$1.62M
Gregory L. Verdine
5 Mar 2025
Director
Exercised, kept
133,000
$2.48
$329.84K
Chandra Vargeese
4 Mar 2025
See Remarks
Exercised, kept
91,754
$2.48
$227.55K
Chandra Vargeese
23 Jan 2025
See Remarks
Exercised, kept
46,000
$2.48
$114.08K
Paul Bolno
25 Nov 2024
President and CEO
Sold after exercise
50,000
$15.00
$750.00K
Paul Bolno
15 Nov 2024
President and CEO
Sold on a plan
51,234
$14.32
$733.67K
Chris Francis
8 Nov 2024
See Remarks
Sold after exercise
36,000
$16.00
$576.00K
Paul Bolno
16 Oct 2024
President and CEO
Sold on a plan
90,474
$15.00
$1.36M
Chris Francis
16 Oct 2024
See Remarks
Sold after exercise
22,500
$13.50
$303.75K
Chris Francis
16 Oct 2024
See Remarks
Sold after exercise
65,625
$13.75
$902.34K
Chris Francis
16 Oct 2024
See Remarks
Sold after exercise
40,997
$13.00
$532.96K
Chris Francis
16 Oct 2024
See Remarks
Sold after exercise
79,714
$14.00
$1.12M
Kyle Moran
11 Oct 2024
Chief Financial Officer
Exercised, kept
25,000
$2.48
$62.00K
GSK plc
27 Sep 2024
10% owner
Buy indirect
2,791,930
$8.00
$22.34M
Kyle Moran
25 Sep 2024
Chief Financial Officer
Sold on a plan
17,146
$9.00
$154.31K
Paul Bolno
21 Aug 2024
President and CEO
Sold on a plan
48,366
$5.78
$279.56K
Chandra Vargeese
22 Jul 2024
See Remarks
Exercised, kept
68,210
$2.48
$169.16K
Kyle Moran
3 Apr 2024
Chief Financial Officer
Sold on a plan
15,630
$6.17
$96.42K
Ra Capital Management, L.p.
11 Dec 2023
Director
Buy indirect
1,000,000
$5.00
$5.00M
GSK plc
7 Dec 2023
10% owner
Buy indirect
3,300,000
$5.00
$16.50M
Kyle Moran
23 Aug 2023
Chief Financial Officer
Sold on a plan
37,062
$4.75
$176.12K
Kyle Moran
16 Feb 2023
Chief Financial Officer
Sell
9,729
$4.04
$39.31K
Chris Francis
16 Feb 2023
See Remarks
Sell
10,258
$4.03
$41.34K
Paul Bolno
16 Feb 2023
President and CEO
Sell
29,400
$4.04
$118.78K
Chandra Vargeese
16 Feb 2023
See Remarks
Sell
10,249
$4.03
$41.30K
Ra Capital Management, L.p.
16 Jun 2022
Director
Buy indirect
9,480,052
$2.15
$20.38M
Chris Francis
5 May 2022
See Remarks
Sell
10,867
$1.72
$18.69K
Michael A. Panzara
5 May 2022
See Remarks
Sell
16,714
$1.72
$28.75K
Kyle Moran
5 May 2022
Chief Financial Officer
Sell
5,021
$1.72
$8.64K
Paul Bolno
5 May 2022
President and CEO
Sell
33,501
$1.72
$57.62K
Chandra Vargeese
5 May 2022
See Remarks
Sell
16,714
$1.72
$28.75K
Michael A. Panzara
16 Feb 2022
See Remarks
Sell
10,603
$2.31
$24.49K
Paul Bolno
16 Feb 2022
President and CEO
Sell
33,150
$2.32
$76.91K
Chandra Vargeese
16 Feb 2022
Chief Technology Officer
Sell
10,603
$2.32
$24.60K
Chris Francis
16 Feb 2022
See Remarks
Sell
10,123
$2.31
$23.38K
Kyle Moran
16 Feb 2022
Chief Financial Officer
Sell
9,204
$2.31
$21.26K
Kyle Moran
24 Mar 2021
Chief Financial Officer
Exercised, kept
10,930
$2.48
$27.11K
Kyle Moran
16 Feb 2021
Chief Financial Officer
Sell
1,722
$10.57
$18.20K
Chandra Vargeese
16 Feb 2021
Chief Technology Officer
Sell
3,145
$10.57
$33.24K
Michael A. Panzara
16 Feb 2021
See Remarks
Sell
2,929
$10.57
$30.96K
Paul Bolno
16 Feb 2021
President and CEO
Sell
11,205
$10.57
$118.44K
Chris Francis
16 Feb 2021
See Remarks
Sell
2,698
$10.57
$28.52K
Paul Bolno
15 Sep 2020
President and CEO
Sold after exercise
100,000
$15.00
$1.50M
Paul Bolno
25 Aug 2020
President and CEO
Sold after exercise
25,000
$12.00
$300.00K
Paul Bolno
2 Jul 2020
President and CEO
Sold after exercise
95,921
$10.27
$985.11K
Paul Bolno
2 Jul 2020
President and CEO
Sold after exercise
4,079
$10.91
$44.50K
Paul Bolno
2 Jul 2020
President and CEO
Sold after exercise
43,068
$10.26
$441.88K
Paul Bolno
2 Jul 2020
President and CEO
Sold after exercise
4,509
$10.82
$48.79K
Chandra Vargeese
18 Feb 2020
Senior VP, Drug Discovery
Sell
3,188
$7.85
$25.03K
Chris Francis
18 Feb 2020
See Remarks
Sell
2,708
$7.85
$21.26K
Paul Bolno
18 Feb 2020
President and CEO
Sell
11,451
$7.85
$89.89K
Michael A. Panzara
18 Feb 2020
Chief Medical Officer
Sell
2,981
$7.85
$23.40K
David G Gaiero
3 Feb 2020
Interim CFO
Sell
651
$7.00
$4.56K
Chandra Vargeese
3 Dec 2019
Senior VP, Drug Discovery
Sold after exercise
6,000
$35.00
$210.00K
Gregory L. Verdine
20 Nov 2019
Director
Sell
2,609
$32.74
$85.42K
Gregory L. Verdine
20 Nov 2019
Director
Sell
3,400
$31.59
$107.41K
Gregory L. Verdine
20 Nov 2019
Director
Sell
24,030
$30.27
$727.39K
Michael A. Panzara
5 Jul 2019
Chief Medical Officer
Sell
445
$27.26
$12.13K
Michael A. Panzara
5 Jul 2019
Chief Medical Officer
Sell
2,613
$26.88
$70.24K
Paul Bolno
15 Mar 2019
President and CEO
Sold after exercise
1,763
$46.00
$81.10K
Paul Bolno
15 Mar 2019
President and CEO
Sold after exercise
8,237
$45.22
$372.48K
Paul Bolno
15 Mar 2019
President and CEO
Sold after exercise
5,065
$45.89
$232.43K
Paul Bolno
15 Mar 2019
President and CEO
Sold after exercise
34,935
$45.45
$1.59M
Michael A. Panzara
11 Mar 2019
Franchise Lead, Neurology
Sell
7,000
$48.00
$336.00K
Chris Francis
19 Feb 2019
See Remarks
Sell
1,709
$36.84
$62.96K
Chandra Vargeese
19 Feb 2019
Senior VP, Drug Discovery
Sell
2,055
$36.84
$75.71K
Paul Bolno
19 Feb 2019
President and CEO
Sell
119
$37.47
$4.46K
Paul Bolno
19 Feb 2019
President and CEO
Sell
7,614
$36.38
$277.00K
Michael A. Panzara
19 Feb 2019
Franchise Lead, Neurology
Sell
1,837
$36.84
$67.67K
Keith Regnante
19 Feb 2019
Chief Financial Officer
Sell
1,298
$36.84
$47.82K
Ra Capital Management, L.p.
24 Jan 2019
Director
Buy indirect
263,158
$38.00
$10.00M
Gregory L. Verdine
14 Nov 2018
Director
Sell
4,300
$39.52
$169.94K
Gregory L. Verdine
14 Nov 2018
Director
Sell
10,700
$38.59
$412.91K
Chris Francis
25 Sep 2018
See Remarks
Sold after exercise
10,543
$56.00
$590.41K
Chandra Vargeese
24 Sep 2018
Senior VP, Drug Discovery
Sold after exercise
3,000
$55.00
$165.00K
Keith Regnante
24 Sep 2018
Chief Financial Officer
Sold after exercise
29,500
$55.00
$1.62M
Chris Francis
24 Sep 2018
See Remarks
Sold after exercise
1,032
$56.00
$57.79K
Chris Francis
9 Jul 2018
See Remarks
Sold after exercise
596
$38.22
$22.78K
Chris Francis
9 Jul 2018
See Remarks
Sold after exercise
23,900
$37.25
$890.28K
Chris Francis
1 Jun 2018
See Remarks
Sold after exercise
24,496
$48.00
$1.18M
Paul Bolno
30 May 2018
President and CEO
Sold after exercise
20,250
$45.00
$911.25K
Chris Francis
30 May 2018
See Remarks
Sold after exercise
24,496
$45.50
$1.11M
Paul Bolno
29 May 2018
President and CEO
Sold after exercise
3,145
$45.00
$141.53K
Paul Bolno
25 May 2018
President and CEO
Sold after exercise
8,316
$45.00
$374.22K
Paul Bolno
2 May 2018
President and CEO
Sold after exercise
18,289
$45.00
$823.01K
Chris Francis
20 Feb 2018
See Remarks
Sold after exercise
11,504
$55.95
$643.65K
Keith Regnante
16 Feb 2018
Chief Financial Officer
Sell
316
$51.85
$16.38K
Michael A. Panzara
16 Feb 2018
Franchise Lead, Neurology
Sell
511
$52.10
$26.62K
Paul Bolno
16 Feb 2018
President and CEO
Sell
2,200
$51.62
$113.56K
Paul Bolno
16 Feb 2018
President and CEO
Sell
514
$51.01
$26.22K
Chris Francis
16 Feb 2018
See Remarks
Sold after exercise
9,412
$55.00
$517.66K
Chris Francis
16 Feb 2018
See Remarks
Sold after exercise
723
$51.80
$37.45K
Michael A. Panzara
15 Feb 2018
Franchise Lead, Neurology
Sold after exercise
18,750
$50.00
$937.50K
Chandra Vargeese
15 Feb 2018
See Remarks
Sold after exercise
2,000
$50.00
$100.00K
Chandra Vargeese
23 Jan 2018
See Remarks
Sold after exercise
2,000
$40.00
$80.00K
Chandra Vargeese
22 Nov 2017
See Remarks
Sold after exercise
1,500
$35.00
$52.50K
Ra Capital Management, L.p.
14 Nov 2017
Director
Buy indirect
23,398
$24.00
$561.55K
Ra Capital Management, L.p.
13 Nov 2017
Director
Buy indirect
400,000
$23.30
$9.32M
Masaharu Tanaka
18 Sep 2017
Director
Sell indirect
6,362
$24.19
$153.90K
Masaharu Tanaka
15 Sep 2017
Director
Sell indirect
14,385
$24.22
$348.40K
Michael A. Panzara
12 Jul 2017
Franchise Lead, Neurology
Sell
7,414
$16.67
$123.62K
Masaharu Tanaka
29 Mar 2017
Director
Sell indirect
433,825
$24.91
$10.81M
Roberto Guerciolini
7 Dec 2016
See Remarks
Exercised, kept
4,000
$2.47
$9.88K
Roberto Guerciolini
7 Dec 2016
See Remarks
Exercised, kept
20,000
$2.47
$49.40K

What was left out

Form 4 filings counted 234
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 74
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 9,171,525
Sales filed before the plan box existed 46
History held since 18 Nov 2015